A detailed history of Schroder Investment Management Group transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 163,896 shares of KYMR stock, worth $5.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
163,896
Previous 143,692 14.06%
Holding current value
$5.79 Million
Previous $6.8 Million 3.04%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$39.06 - $51.84 $789,168 - $1.05 Million
20,204 Added 14.06%
163,896 $6.59 Million
Q3 2024

Nov 13, 2024

SELL
$30.16 - $52.4 $558,231 - $969,871
-18,509 Reduced 11.41%
143,692 $6.8 Million
Q2 2024

Aug 12, 2024

BUY
$29.85 - $39.42 $1.23 Million - $1.63 Million
41,354 Added 34.22%
162,201 $4.84 Million
Q1 2024

May 14, 2024

SELL
$22.9 - $43.57 $1.48 Million - $2.81 Million
-64,452 Reduced 34.78%
120,847 $4.86 Million
Q4 2023

Feb 13, 2024

SELL
$10.97 - $26.84 $463,822 - $1.13 Million
-42,281 Reduced 18.58%
185,299 $4.72 Million
Q3 2023

Nov 14, 2023

BUY
$13.9 - $23.88 $38,211 - $65,646
2,749 Added 1.22%
227,580 $3.16 Million
Q2 2023

Aug 11, 2023

BUY
$22.4 - $34.92 $5.04 Million - $7.85 Million
224,831 New
224,831 $5.17 Million
Q1 2022

May 16, 2022

SELL
$35.3 - $64.68 $1.02 Million - $1.88 Million
-28,989 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$49.91 - $65.56 $1.45 Million - $1.9 Million
28,989 New
28,989 $1.84 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.93B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.